Movement Disorders (revue)

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Identifieur interne : 000376 ( PubMed/Checkpoint ); précédent : 000375; suivant : 000377

Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.

Auteurs : Daniela Berg [Allemagne] ; Ronald B. Postuma ; Bastiaan Bloem ; Piu Chan ; Bruno Dubois ; Thomas Gasser ; Christopher G. Goetz ; Glenda M. Halliday ; John Hardy ; Anthony E. Lang ; Irene Litvan ; Kenneth Marek ; José Obeso ; Wolfgang Oertel ; C Warren Olanow ; Werner Poewe [Autriche] ; Matthew Stern ; Günther Deuschl

Source :

RBID : pubmed:24619848

English descriptors

Abstract

With advances in knowledge disease, boundaries may change. Occasionally, these changes are of such a magnitude that they require redefinition of the disease. In recognition of the profound changes in our understanding of Parkinson's disease (PD), the International Parkinson and Movement Disorders Society (MDS) commissioned a task force to consider a redefinition of PD. This review is a discussion article, intended as the introductory statement of the task force. Several critical issues were identified that challenge current PD definitions. First, new findings challenge the central role of the classical pathologic criteria as the arbiter of diagnosis, notably genetic cases without synuclein deposition, the high prevalence of incidental Lewy body (LB) deposition, and the nonmotor prodrome of PD. It remains unclear, however, whether these challenges merit a change in the pathologic gold standard, especially considering the limitations of alternate gold standards. Second, the increasing recognition of dementia in PD challenges the distinction between diffuse LB disease and PD. Consideration might be given to removing dementia as an exclusion criterion for PD diagnosis. Third, there is increasing recognition of disease heterogeneity, suggesting that PD subtypes should be formally identified; however, current subtype classifications may not be sufficiently robust to warrant formal delineation. Fourth, the recognition of a nonmotor prodrome of PD requires that new diagnostic criteria for early-stage and prodromal PD should be created; here, essential features of these criteria are proposed. Finally, there is a need to create new MDS diagnostic criteria that take these changes in disease definition into consideration.

DOI: 10.1002/mds.25844
PubMed: 24619848


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:24619848

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.</title>
<author>
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Postuma, Ronald B" sort="Postuma, Ronald B" uniqKey="Postuma R" first="Ronald B" last="Postuma">Ronald B. Postuma</name>
</author>
<author>
<name sortKey="Bloem, Bastiaan" sort="Bloem, Bastiaan" uniqKey="Bloem B" first="Bastiaan" last="Bloem">Bastiaan Bloem</name>
</author>
<author>
<name sortKey="Chan, Piu" sort="Chan, Piu" uniqKey="Chan P" first="Piu" last="Chan">Piu Chan</name>
</author>
<author>
<name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
</author>
<author>
<name sortKey="Gasser, Thomas" sort="Gasser, Thomas" uniqKey="Gasser T" first="Thomas" last="Gasser">Thomas Gasser</name>
</author>
<author>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name>
</author>
<author>
<name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
</author>
<author>
<name sortKey="Hardy, John" sort="Hardy, John" uniqKey="Hardy J" first="John" last="Hardy">John Hardy</name>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
</author>
<author>
<name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
</author>
<author>
<name sortKey="Marek, Kenneth" sort="Marek, Kenneth" uniqKey="Marek K" first="Kenneth" last="Marek">Kenneth Marek</name>
</author>
<author>
<name sortKey="Obeso, Jose" sort="Obeso, Jose" uniqKey="Obeso J" first="José" last="Obeso">José Obeso</name>
</author>
<author>
<name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name>
</author>
<author>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author>
<name sortKey="Stern, Matthew" sort="Stern, Matthew" uniqKey="Stern M" first="Matthew" last="Stern">Matthew Stern</name>
</author>
<author>
<name sortKey="Deuschl, Gunther" sort="Deuschl, Gunther" uniqKey="Deuschl G" first="Günther" last="Deuschl">Günther Deuschl</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2014">2014</date>
<idno type="RBID">pubmed:24619848</idno>
<idno type="pmid">24619848</idno>
<idno type="doi">10.1002/mds.25844</idno>
<idno type="wicri:Area/PubMed/Corpus">000553</idno>
<idno type="wicri:Area/PubMed/Curation">000553</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000376</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.</title>
<author>
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
<affiliation wicri:level="3">
<nlm:affiliation>Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany.</nlm:affiliation>
<country xml:lang="fr">Allemagne</country>
<wicri:regionArea>Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen</wicri:regionArea>
<placeName>
<region type="land" nuts="1">Bade-Wurtemberg</region>
<region type="district" nuts="2">District de Tübingen</region>
<settlement type="city">Tübingen</settlement>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Postuma, Ronald B" sort="Postuma, Ronald B" uniqKey="Postuma R" first="Ronald B" last="Postuma">Ronald B. Postuma</name>
</author>
<author>
<name sortKey="Bloem, Bastiaan" sort="Bloem, Bastiaan" uniqKey="Bloem B" first="Bastiaan" last="Bloem">Bastiaan Bloem</name>
</author>
<author>
<name sortKey="Chan, Piu" sort="Chan, Piu" uniqKey="Chan P" first="Piu" last="Chan">Piu Chan</name>
</author>
<author>
<name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
</author>
<author>
<name sortKey="Gasser, Thomas" sort="Gasser, Thomas" uniqKey="Gasser T" first="Thomas" last="Gasser">Thomas Gasser</name>
</author>
<author>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name>
</author>
<author>
<name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
</author>
<author>
<name sortKey="Hardy, John" sort="Hardy, John" uniqKey="Hardy J" first="John" last="Hardy">John Hardy</name>
</author>
<author>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
</author>
<author>
<name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
</author>
<author>
<name sortKey="Marek, Kenneth" sort="Marek, Kenneth" uniqKey="Marek K" first="Kenneth" last="Marek">Kenneth Marek</name>
</author>
<author>
<name sortKey="Obeso, Jose" sort="Obeso, Jose" uniqKey="Obeso J" first="José" last="Obeso">José Obeso</name>
</author>
<author>
<name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name>
</author>
<author>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
</author>
<author>
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
<affiliation>
<country>Autriche</country>
<placeName>
<settlement type="city">Innsbruck</settlement>
<region nuts="2" type="region">Tyrol (Land)</region>
</placeName>
<orgName type="university">Université de médecine d'Innsbruck</orgName>
</affiliation>
</author>
<author>
<name sortKey="Stern, Matthew" sort="Stern, Matthew" uniqKey="Stern M" first="Matthew" last="Stern">Matthew Stern</name>
</author>
<author>
<name sortKey="Deuschl, Gunther" sort="Deuschl, Gunther" uniqKey="Deuschl G" first="Günther" last="Deuschl">Günther Deuschl</name>
</author>
</analytic>
<series>
<title level="j">Movement disorders : official journal of the Movement Disorder Society</title>
<idno type="eISSN">1531-8257</idno>
<imprint>
<date when="2014" type="published">2014</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Advisory Committees</term>
<term>Diagnostic and Statistical Manual of Mental Disorders</term>
<term>Humans</term>
<term>Neuropsychological Tests</term>
<term>Parkinson Disease (diagnosis)</term>
<term>Parkinson Disease (pathology)</term>
</keywords>
<keywords scheme="MESH" qualifier="diagnosis" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en">
<term>Parkinson Disease</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Advisory Committees</term>
<term>Diagnostic and Statistical Manual of Mental Disorders</term>
<term>Humans</term>
<term>Neuropsychological Tests</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">With advances in knowledge disease, boundaries may change. Occasionally, these changes are of such a magnitude that they require redefinition of the disease. In recognition of the profound changes in our understanding of Parkinson's disease (PD), the International Parkinson and Movement Disorders Society (MDS) commissioned a task force to consider a redefinition of PD. This review is a discussion article, intended as the introductory statement of the task force. Several critical issues were identified that challenge current PD definitions. First, new findings challenge the central role of the classical pathologic criteria as the arbiter of diagnosis, notably genetic cases without synuclein deposition, the high prevalence of incidental Lewy body (LB) deposition, and the nonmotor prodrome of PD. It remains unclear, however, whether these challenges merit a change in the pathologic gold standard, especially considering the limitations of alternate gold standards. Second, the increasing recognition of dementia in PD challenges the distinction between diffuse LB disease and PD. Consideration might be given to removing dementia as an exclusion criterion for PD diagnosis. Third, there is increasing recognition of disease heterogeneity, suggesting that PD subtypes should be formally identified; however, current subtype classifications may not be sufficiently robust to warrant formal delineation. Fourth, the recognition of a nonmotor prodrome of PD requires that new diagnostic criteria for early-stage and prodromal PD should be created; here, essential features of these criteria are proposed. Finally, there is a need to create new MDS diagnostic criteria that take these changes in disease definition into consideration.</div>
</front>
</TEI>
<pubmed>
<MedlineCitation Owner="NLM" Status="MEDLINE">
<PMID Version="1">24619848</PMID>
<DateCreated>
<Year>2014</Year>
<Month>04</Month>
<Day>04</Day>
</DateCreated>
<DateCompleted>
<Year>2014</Year>
<Month>12</Month>
<Day>03</Day>
</DateCompleted>
<DateRevised>
<Year>2015</Year>
<Month>02</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print-Electronic">
<Journal>
<ISSN IssnType="Electronic">1531-8257</ISSN>
<JournalIssue CitedMedium="Internet">
<Volume>29</Volume>
<Issue>4</Issue>
<PubDate>
<Year>2014</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Movement disorders : official journal of the Movement Disorder Society</Title>
<ISOAbbreviation>Mov. Disord.</ISOAbbreviation>
</Journal>
<ArticleTitle>Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.</ArticleTitle>
<Pagination>
<MedlinePgn>454-62</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1002/mds.25844</ELocationID>
<Abstract>
<AbstractText>With advances in knowledge disease, boundaries may change. Occasionally, these changes are of such a magnitude that they require redefinition of the disease. In recognition of the profound changes in our understanding of Parkinson's disease (PD), the International Parkinson and Movement Disorders Society (MDS) commissioned a task force to consider a redefinition of PD. This review is a discussion article, intended as the introductory statement of the task force. Several critical issues were identified that challenge current PD definitions. First, new findings challenge the central role of the classical pathologic criteria as the arbiter of diagnosis, notably genetic cases without synuclein deposition, the high prevalence of incidental Lewy body (LB) deposition, and the nonmotor prodrome of PD. It remains unclear, however, whether these challenges merit a change in the pathologic gold standard, especially considering the limitations of alternate gold standards. Second, the increasing recognition of dementia in PD challenges the distinction between diffuse LB disease and PD. Consideration might be given to removing dementia as an exclusion criterion for PD diagnosis. Third, there is increasing recognition of disease heterogeneity, suggesting that PD subtypes should be formally identified; however, current subtype classifications may not be sufficiently robust to warrant formal delineation. Fourth, the recognition of a nonmotor prodrome of PD requires that new diagnostic criteria for early-stage and prodromal PD should be created; here, essential features of these criteria are proposed. Finally, there is a need to create new MDS diagnostic criteria that take these changes in disease definition into consideration.</AbstractText>
<CopyrightInformation>© 2014 International Parkinson and Movement Disorder Society.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y">
<Author ValidYN="Y">
<LastName>Berg</LastName>
<ForeName>Daniela</ForeName>
<Initials>D</Initials>
<AffiliationInfo>
<Affiliation>Department of Neurodegeneration, Hertie Institute for Clinical Brain Research and German Center of Neurodegenerative Diseases, Tuebingen, Germany.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y">
<LastName>Postuma</LastName>
<ForeName>Ronald B</ForeName>
<Initials>RB</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Bloem</LastName>
<ForeName>Bastiaan</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Chan</LastName>
<ForeName>Piu</ForeName>
<Initials>P</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Dubois</LastName>
<ForeName>Bruno</ForeName>
<Initials>B</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Gasser</LastName>
<ForeName>Thomas</ForeName>
<Initials>T</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Goetz</LastName>
<ForeName>Christopher G</ForeName>
<Initials>CG</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Halliday</LastName>
<ForeName>Glenda M</ForeName>
<Initials>GM</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Hardy</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Lang</LastName>
<ForeName>Anthony E</ForeName>
<Initials>AE</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Litvan</LastName>
<ForeName>Irene</ForeName>
<Initials>I</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Marek</LastName>
<ForeName>Kenneth</ForeName>
<Initials>K</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Obeso</LastName>
<ForeName>José</ForeName>
<Initials>J</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Oertel</LastName>
<ForeName>Wolfgang</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Olanow</LastName>
<ForeName>C Warren</ForeName>
<Initials>CW</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Poewe</LastName>
<ForeName>Werner</ForeName>
<Initials>W</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Stern</LastName>
<ForeName>Matthew</ForeName>
<Initials>M</Initials>
</Author>
<Author ValidYN="Y">
<LastName>Deuschl</LastName>
<ForeName>Günther</ForeName>
<Initials>G</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<GrantList CompleteYN="Y">
<Grant>
<GrantID>089698</GrantID>
<Agency>Wellcome Trust</Agency>
<Country>United Kingdom</Country>
</Grant>
<Grant>
<GrantID>G0701075</GrantID>
<Agency>Medical Research Council</Agency>
<Country>United Kingdom</Country>
</Grant>
</GrantList>
<PublicationTypeList>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016454">Review</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic">
<Year>2014</Year>
<Month>03</Month>
<Day>11</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo>
<Country>United States</Country>
<MedlineTA>Mov Disord</MedlineTA>
<NlmUniqueID>8610688</NlmUniqueID>
<ISSNLinking>0885-3185</ISSNLinking>
</MedlineJournalInfo>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Neurol. 1990;53:245-9</RefSource>
<PMID Version="1">2239463</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Jul;27(8):996-1003</RefSource>
<PMID Version="1">22733427</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 1992 Jan;42(1 Suppl 1):6-16; discussion 57-60</RefSource>
<PMID Version="1">1549203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 1992 Mar;55(3):181-4</RefSource>
<PMID Version="1">1564476</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 1992;32 Suppl:S125-7</RefSource>
<PMID Version="1">1510370</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neurol Scand. 1994 Apr;89(4):242-51</RefSource>
<PMID Version="1">8042440</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 1999 Jan;14(1):10-20</RefSource>
<PMID Version="1">9918339</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 1999 Jan;56(1):33-9</RefSource>
<PMID Version="1">9923759</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neuron. 2004 Nov 18;44(4):601-7</RefSource>
<PMID Version="1">15541309</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2005 Feb;62(2):297-302</RefSource>
<PMID Version="1">15710859</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2005 Mar;76(3):343-8</RefSource>
<PMID Version="1">15716523</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Lancet Neurol. 2006 Jan;5(1):75-86</RefSource>
<PMID Version="1">16361025</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2012 Aug 28;79(9):906-14</RefSource>
<PMID Version="1">22895591</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Nov;27(13):1625-31</RefSource>
<PMID Version="1">23038629</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2012 Dec 11;79(24):2307-14</RefSource>
<PMID Version="1">23152586</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2013 Apr;84(4):409-15</RefSource>
<PMID Version="1">22952329</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Am J Epidemiol. 2003 Jun 1;157(11):1015-22</RefSource>
<PMID Version="1">12777365</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2004 Jul 27;63(2):305-11</RefSource>
<PMID Version="1">15277625</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 1988 Jun;51(6):745-52</RefSource>
<PMID Version="1">2841426</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2005 Dec 27;65(12):1863-72</RefSource>
<PMID Version="1">16237129</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2006 Feb;77(2):275-6</RefSource>
<PMID Version="1">16421140</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2006 Apr 11;66(7):968-75</RefSource>
<PMID Version="1">16606907</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2007 Mar 13;68(11):812-9</RefSource>
<PMID Version="1">17353469</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain Pathol. 2007 Jan;17(1):24-30</RefSource>
<PMID Version="1">17493034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Aug 15;22(11):1581-6</RefSource>
<PMID Version="1">17523195</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Sep 15;22(12):1681-8</RefSource>
<PMID Version="1">17534951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Oct 15;22(13):1839-51; quiz 1988</RefSource>
<PMID Version="1">17595026</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2007 Dec;22(16):2314-24</RefSource>
<PMID Version="1">18098298</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2008 Feb;63(2):167-73</RefSource>
<PMID Version="1">18067173</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2008 Apr;115(4):437-44</RefSource>
<PMID Version="1">18264713</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2008 Apr;115(4):399-407</RefSource>
<PMID Version="1">18297293</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2008 May 13;70(20):1916-25</RefSource>
<PMID Version="1">18474848</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol. 2008 May;255(5):716-22</RefSource>
<PMID Version="1">18344057</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2008 Nov 15;23(15):2248-50</RefSource>
<PMID Version="1">18823039</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Int Psychogeriatr. 2009 Apr;21(2):220-4</RefSource>
<PMID Version="1">19173763</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2009 Jun;15(5):379-82</RefSource>
<PMID Version="1">18977165</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Neurosurg Psychiatry. 2009 Jul;80(7):805-7</RefSource>
<PMID Version="1">19531689</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2009 Nov;132(Pt 11):2947-57</RefSource>
<PMID Version="1">19759203</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2009 Nov 15;24(15):2225-32</RefSource>
<PMID Version="1">19768814</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2010 Mar 16;74(11):885-92</RefSource>
<PMID Version="1">20181924</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurodegener Dis. 2010;7(1-3):175-9</RefSource>
<PMID Version="1">20197701</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Acta Neuropathol. 2010 Jun;119(6):689-702</RefSource>
<PMID Version="1">20306269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2010 Jun;16(5):307-15</RefSource>
<PMID Version="1">20338799</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2010 Jun;133(Pt 6):1747-54</RefSource>
<PMID Version="1">20413575</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2010 Jun;67(6):715-25</RefSource>
<PMID Version="1">20517933</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2001 Oct 23;57(8):1497-9</RefSource>
<PMID Version="1">11673599</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Brain. 2002 Apr;125(Pt 4):861-70</RefSource>
<PMID Version="1">11912118</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2002 Nov;59(11):1724-8</RefSource>
<PMID Version="1">12433259</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Adv Neurol. 2003;91:133-42</RefSource>
<PMID Version="1">12442672</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurobiol Aging. 2003 Mar-Apr;24(2):197-211</RefSource>
<PMID Version="1">12498954</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2010 Jun 15;25(8):969-78</RefSource>
<PMID Version="1">20535823</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Jan;26(1):51-8</RefSource>
<PMID Version="1">21322019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>J Neurol Sci. 2011 May 15;304(1-2):61-6</RefSource>
<PMID Version="1">21377694</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2011 Feb 15;26(3):399-406</RefSource>
<PMID Version="1">21264941</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Arch Neurol. 2011 Jul;68(7):932-7</RefSource>
<PMID Version="1">21747034</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Parkinsonism Relat Disord. 2011 Dec;17(10):724-9</RefSource>
<PMID Version="1">21571570</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Jan;27(1):72-8</RefSource>
<PMID Version="1">22038951</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Ann Neurol. 2012 Feb;71(2):258-66</RefSource>
<PMID Version="1">22367997</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Pract Neurol. 2012 Apr;12(2):77-87</RefSource>
<PMID Version="1">22450452</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Neurology. 2012 Mar 27;78(13):1016-24</RefSource>
<PMID Version="1">22454269</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 May;27(6):720-6</RefSource>
<PMID Version="1">22322798</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Mov Disord. 2012 Jun;27(7):831-42</RefSource>
<PMID Version="1">22451330</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites">
<RefSource>Can J Neurol Sci. 1991 Aug;18(3):275-8</RefSource>
<PMID Version="1">1913360</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D026683">Advisory Committees</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D039721">Diagnostic and Statistical Manual of Mental Disorders</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D006801">Humans</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D009483">Neuropsychological Tests</DescriptorName>
</MeshHeading>
<MeshHeading>
<DescriptorName MajorTopicYN="N" UI="D010300">Parkinson Disease</DescriptorName>
<QualifierName MajorTopicYN="Y" UI="Q000175">diagnosis</QualifierName>
<QualifierName MajorTopicYN="N" UI="Q000473">pathology</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">EMS58823</OtherID>
<OtherID Source="NLM">PMC4204150</OtherID>
<KeywordList Owner="NOTNLM">
<Keyword MajorTopicYN="N">MDS diagnostic criteria</Keyword>
<Keyword MajorTopicYN="N">disease heterogeneity</Keyword>
<Keyword MajorTopicYN="N">gold standard</Keyword>
<Keyword MajorTopicYN="N">nonmotor prodrome</Keyword>
<Keyword MajorTopicYN="N">redefinition of PD</Keyword>
<Keyword MajorTopicYN="N">subtypes</Keyword>
</KeywordList>
</MedlineCitation>
<PubmedData>
<History>
<PubMedPubDate PubStatus="received">
<Year>2013</Year>
<Month>4</Month>
<Day>24</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised">
<Year>2013</Year>
<Month>11</Month>
<Day>27</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted">
<Year>2013</Year>
<Month>12</Month>
<Day>3</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="aheadofprint">
<Year>2014</Year>
<Month>3</Month>
<Day>11</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez">
<Year>2014</Year>
<Month>3</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed">
<Year>2014</Year>
<Month>3</Month>
<Day>13</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline">
<Year>2014</Year>
<Month>12</Month>
<Day>15</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList>
<ArticleId IdType="pubmed">24619848</ArticleId>
<ArticleId IdType="doi">10.1002/mds.25844</ArticleId>
<ArticleId IdType="pmc">PMC4204150</ArticleId>
<ArticleId IdType="mid">EMS58823</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations>
<list>
<country>
<li>Allemagne</li>
<li>Autriche</li>
</country>
<region>
<li>Bade-Wurtemberg</li>
<li>District de Tübingen</li>
<li>Tyrol (Land)</li>
</region>
<settlement>
<li>Innsbruck</li>
<li>Tübingen</li>
</settlement>
<orgName>
<li>Université de médecine d'Innsbruck</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Bloem, Bastiaan" sort="Bloem, Bastiaan" uniqKey="Bloem B" first="Bastiaan" last="Bloem">Bastiaan Bloem</name>
<name sortKey="Chan, Piu" sort="Chan, Piu" uniqKey="Chan P" first="Piu" last="Chan">Piu Chan</name>
<name sortKey="Deuschl, Gunther" sort="Deuschl, Gunther" uniqKey="Deuschl G" first="Günther" last="Deuschl">Günther Deuschl</name>
<name sortKey="Dubois, Bruno" sort="Dubois, Bruno" uniqKey="Dubois B" first="Bruno" last="Dubois">Bruno Dubois</name>
<name sortKey="Gasser, Thomas" sort="Gasser, Thomas" uniqKey="Gasser T" first="Thomas" last="Gasser">Thomas Gasser</name>
<name sortKey="Goetz, Christopher G" sort="Goetz, Christopher G" uniqKey="Goetz C" first="Christopher G" last="Goetz">Christopher G. Goetz</name>
<name sortKey="Halliday, Glenda M" sort="Halliday, Glenda M" uniqKey="Halliday G" first="Glenda M" last="Halliday">Glenda M. Halliday</name>
<name sortKey="Hardy, John" sort="Hardy, John" uniqKey="Hardy J" first="John" last="Hardy">John Hardy</name>
<name sortKey="Lang, Anthony E" sort="Lang, Anthony E" uniqKey="Lang A" first="Anthony E" last="Lang">Anthony E. Lang</name>
<name sortKey="Litvan, Irene" sort="Litvan, Irene" uniqKey="Litvan I" first="Irene" last="Litvan">Irene Litvan</name>
<name sortKey="Marek, Kenneth" sort="Marek, Kenneth" uniqKey="Marek K" first="Kenneth" last="Marek">Kenneth Marek</name>
<name sortKey="Obeso, Jose" sort="Obeso, Jose" uniqKey="Obeso J" first="José" last="Obeso">José Obeso</name>
<name sortKey="Oertel, Wolfgang" sort="Oertel, Wolfgang" uniqKey="Oertel W" first="Wolfgang" last="Oertel">Wolfgang Oertel</name>
<name sortKey="Olanow, C Warren" sort="Olanow, C Warren" uniqKey="Olanow C" first="C Warren" last="Olanow">C Warren Olanow</name>
<name sortKey="Postuma, Ronald B" sort="Postuma, Ronald B" uniqKey="Postuma R" first="Ronald B" last="Postuma">Ronald B. Postuma</name>
<name sortKey="Stern, Matthew" sort="Stern, Matthew" uniqKey="Stern M" first="Matthew" last="Stern">Matthew Stern</name>
</noCountry>
<country name="Allemagne">
<region name="Bade-Wurtemberg">
<name sortKey="Berg, Daniela" sort="Berg, Daniela" uniqKey="Berg D" first="Daniela" last="Berg">Daniela Berg</name>
</region>
</country>
<country name="Autriche">
<region name="Tyrol (Land)">
<name sortKey="Poewe, Werner" sort="Poewe, Werner" uniqKey="Poewe W" first="Werner" last="Poewe">Werner Poewe</name>
</region>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/PubMed/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000376 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd -nk 000376 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:24619848
   |texte=   Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/RBID.i   -Sk "pubmed:24619848" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a MovDisordV3 

Wicri

This area was generated with Dilib version V0.6.23.
Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024